Bormioli Pharma Plans Italian Plant Investment

Pharmaceutical glassmaker Bormioli Pharma wants to invest in its San Vito al Tagliamento, Italy factory. The group plans to invest €22m with the aim of increasing turnover from €20m to €28m. Work will begin August 2019 and reach full capacity by 2021. The plant may stop production of glass tubes and manufacture hollow glass instead. The number of employees at the plant will rise from 80 to 125. Bormili Pharma was established at the end of 2017 after it was transferred by the Bormioli Rocco group. Today, it is owned by Triton Capital Investment Fund.